Ecuador vs Luxembourg: Estimated antiretroviral therapy coverage among people living with HIV
Ecuador
84.0%
in 2025
Luxembourg
84.0%
in 2025
Ecuador rank
37th
Luxembourg rank
37th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Ecuador
- Luxembourg
How they compare
Ecuador currently reports 84.0% against 84.0% in Luxembourg, a difference of 0.0%.
Across all 26 years both countries report, Luxembourg has been ahead every year.
Ecuador ranks 37th and Luxembourg ranks 37th of 143 countries.
Luxembourg has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ecuador | Luxembourg | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.2% | 46.1% | 40.9% | Luxembourg |
| 2010s | 36.1% | 67.8% | 31.7% | Luxembourg |
| 2020s | 74.7% | 82.7% | 8.0% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Ecuador or Luxembourg?
- Ecuador, at 84.0% against 84.0% in Luxembourg as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Ecuador and Luxembourg?
- 0.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Luxembourg?
- 26 years are reported by both, from 2000 to 2025.
- How do Ecuador and Luxembourg rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Ecuador ranks 37th and Luxembourg ranks 37th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.